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Prion protein-detergent micelle interactions studied by NMR in
solution
Abstract
Cellular prion proteins, PrP(C), carrying the amino acid substitutions P102L, P105L, or A117V, which
confer increased susceptibility to human transmissible spongiform encephalopathies, are known to form
structures that include transmembrane polypeptide segments. Herein, we investigated the interactions
between dodecylphosphocholine micelles and the polypeptide fragments 90-231 of the recombinant
mouse PrP variants carrying the amino acid replacements P102L, P105L, A117V,
A113V/A115V/A118V, K110I/H111I, M129V, P105L/M129V, and A117V/M129V. Wild-type
mPrP-(90-231) and mPrP[M129V]-(91-231) showed only weak interactions with
dodecylphosphocholine micelles in aqueous solution at pH 7.0, whereas discrete interaction sites within
the polypeptide segment 102-127 were identified for all other aforementioned mPrP variants by NMR
chemical shift mapping. These model studies thus provide evidence that amino acid substitutions within
the polypeptide segment 102-127 affect the interactions of PrP(C) with membranous structures, which
might in turn modulate the physiological function of the protein in health and disease.
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Cellular prion proteins, PrPC, carrying the 
amino acid substitutions P102L, P105L or 
A117V, which confer increased susceptibility to 
human transmissible spongiform 
encephalopathies, are known to form structures 
that include transmembrane polypeptide 
segments. We now investigated the interactions 
between dodecylphosphocholine micelles and 
the polypeptide fragments 90–231 of the 
recombinant mouse PrP variants carrying the 
amino acid replacements P102L, P105L, 
A117V, A113V/A115V/A118V, K110I/H111I, 
M129V, P105L/M129V and A117V/M129V. 
Wild-type mPrP(90–231) and 
mPrP[M129V](91–231) showed only weak 
interactions with DPC micelles in aqueous 
solution at pH = 7.0, whereas discrete 
interaction sites within the polypeptide segment 
102–127 were identified for all other 
aforementioned mPrP variants by NMR 
chemical shift mapping. These model studies 
thus provide evidence that amino acid 
substitutions within the polypeptide segment 
102–127 affect the interactions of PrPC with 
membranous structures, which might in turn 
modulate the physiological function of the 
protein in health and disease. 
Transmissible spongiform encephalopathies 
(TSE), such as Creutzfeldt-Jakob disease (CJD) 
and the Gerstmann-Sträussler-Scheinker syndrome 
(GSS) in humans, are accompanied by the 
appearance in the brain of an aggregated “scrapie” 
isoform of the host-encoded prion protein, PrPSc 
(ref. (1-3)). The cellular form, PrPC, consists of an 
unstructured N-terminal “tail” of residues 23–125
and a globular domain of residues 126–231, and is 
attached by a C-terminal glycosyl-
phosphatidylinositol (GPI) anchor to the outer 
plasma membrane. This structure ensures a role of 
membrane interactions in the physiological 
function of PrPC and probably also in the disease-
related events leading to transmissible spongiform 
encephalopathies. For example, transgenic mice 
expressing a prion protein variant lacking the GPI 
membrane anchor did not develop the typical 
clinical signs of a TSE after inoculation with 
infectious brain homogenate, although significant 
amounts of PrPSc accumulated in the brain (4). 
This finding led to the conclusion that membrane-
association of PrPC is necessary for the 
development of a TSE. Independent evidence for 
the importance of membrane interactions for the 
onset of prion diseases was derived from cell-free 
conversion assays and cell culture experiments 
(5,6).  
Data have also been presented which indicate 
that in addition to the normal form with the C-
terminus linked to a GPI anchor and the C-
terminal domain located on the cell surface, PrPC 
can adopt two different transmembrane topologies, 
CtmPrP and NtmPrP, which have the C-terminal 
polypeptide segment located in the lumen of the 
endoplasmic reticulum (CtmPrP) or in the 
cytoplasm (NtmPrP) (7-9). The population of the 
CtmPrP variant is less than 10% of the total wild-
type prion protein present during cellular 
biosynthesis, but is increased to 20–30% for the 
pathogenic mutations P102L, P105L, and A117V 
of human PrP, and the designed variant mouse 
PrPs obtained with the amino acid exchanges 
A113V/A115V/A118V and K110I/H111I (10-13). 
The population of CtmPrP was further increased 
when an additional mutation, L9R, was present in 
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the N-terminal signal sequence (14), so that 
approximately 50% of the PrP was synthesized as 
the CtmPrP variant in granule neurons obtained 
from transgenic mice expressing a prion protein 
construct carrying the four amino acid 
replacements L9R, A113V, A115V, and A118V 
(15). Quite generally, an increase in the population 
of CtmPrP was also shown to be associated with 
severe neurodegeneration in transgenic mice and it 
has been suggested that CtmPrP may be the 
proximate cause of neuronal death in certain prion 
disorders (10,11,15).   
In vitro studies on interactions of full-length 
and N-terminally truncated forms of recombinant 
PrP showed that acidic membranes caused the N-
terminal part of the protein to become more 
structured, whereas the C-terminal domain was 
destabilized (16-19). Furthermore, zwitterionic 
gel-phase dipalmitoylphosphatidylcholine (DPPC) 
or raft-like membranes were shown to induce 
increased -helical structure in recombinant 
Syrian hamster PrP(90–231) at pH = 7.0 (18,19). 
Membrane interactions of polypeptides 
representing sequence motifs found in the prion 
protein have also been studied (20-23).  
In this paper we describe investigations of PrP 
interactions with a membrane mimetic and focus 
on the mutations P102L, P105L and A117V, 
which have been linked with familial GSS in 
humans (2,24,25). Our interest in these variant 
proteins is related to open questions about the 
mechanisms by which pathogenic mutations 
predispose humans for prion diseases. We studied 
the interactions of a recombinant wild-type mouse 
prion protein fragment, mPrP(90–231), and the 
variants mPrP[P102L](91–231), 
mPrP[P105L](91–231), mPrP[A117V](90–231), 
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231). For these studies, 
we used the N-terminally truncated protein 
composed of residues 90231. This region 
contains the transmembrane segment, all known 
disease-associated point mutations, the entire 
polypeptide fragment with proteinase K-resistance 
in PrPSc, which is also sufficient to transmit 
disease (1,25,26). The amino acid substitutions in 
these variant PrPs are located either within a 
hydrophobic stretch of residues 112–127, which is 
highly conserved in mammalian PrPs (27,28), or 
in the positively charged segment of residues 95–
111 (Fig. 1B,C). We also included the M129V 
polymorphism into this study, which was reported 
to have a significant influence on the susceptibility 
of humans to prion diseases and on the disease 
phenotype. For example, the mutations P105L and 
A117V are only pathogenic in the presence of 
valine at position 129 (2,24). The zwitterionic 
detergent dodecylphosphocholine (DPC; Fig. 1A) 
was used as a biomembrane mimetic model 
system, and nuclear magnetic resonance (NMR) 
spectroscopy was employed to screen for protein–
detergent micelle interactions, and for the 
structural characterization of the various prion 
protein constructs interacting with the detergent 
micelles.  
 
Experimental Procedures 
Expression plasmids, expression and purification 
of mPrP(90–231) and variants thereof – The 
construction of the plasmids encoding the mouse 
PrP polypeptide segments mPrP(91–231), 
mPrP[P102L](91–231) and mPrP[P105L](91–231) 
has been described (29). The plasmids for other 
mouse prion protein variants were obtained with 
mPrP(90–231) or mPrP(91–231) as a template, 
using the QuikChangeTM site-directed mutagenesis 
protocol (Stratagene) according to the instructions 
by the manufacturer. The following mutagenesis 
primers were used: 5’–AGG GGC TGC GGT 
AGC TGG GGC AG–3’ and 5’–CTG CCC CAG 
CTA CCG CAG CCC CT–3’ for 
mPrP[A117V](90–231), 5’–CCA ACC TCA AGC 
ATG TGG TAG GGG TCG CGG CAG TGG 
GGG CAG TAG TGG GGG GCC TTG GT–3’ 
and 5’–ACC AAG GCC CCC CAC TAC TGC 
CCC CAC TGC CGC GAC CCC TAC CAC ATG 
CTT GAG GTT GG–3’ for 
mPrP[A113V,A115V,A118V](90–231), 5’–CCA 
AAA ACC AAC CTC ATC ATC GTG GCA 
GGG GCT GCG GCA–3’ and 5’–TGC CGC AGC 
CCC TGC CAC GAT GAT GAG GTT GGT TTT 
TGG–3’ for mPrP[K110I,H111I](90–231), and 
5’–CTT GGT GGC TAC GTG CTG GGG AGC 
GCC ATG–3’ and 5’–CAT GGC GCT CCC CAG 
CAC GTA GCC ACC AAG–3’ for 
mPrP[M129V](91–231). For the generation of  
mPrP[P105L,M129V](91–231) and 
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mPrP[A117V,M129V](90–231), the plasmids 
mPrP[P105L](91–231) and mPrP[A117V](90–
231), respectively, were used as templates with the 
same mutagenesis primers as applied for the 
generation of mPrP[M129V](91–231). 
All the aforementioned constructs were 
expressed and purified as uniformly 15N-labeled 
proteins (29,30). mPrP(90–231), 
mPrP[M129V](91–231), mPrP[P102L](91–231), 
mPrP[P105L](91–231), mPrP[A117V](90–231), 
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231) were also produced 
as uniformly 13C,15N-labeled proteins (29,30).
NMR spectroscopy – Uniformly 15N- or 
13C,15N-labeled protein samples were prepared in 5 
mM sodium phosphate buffer at pH = 7.0 in 90% 
H2O/10% D2O. The protein concentration was 
1.0–1.4 mM, unless otherwise indicated. Tentative 
initial backbone 1HN, 15N, 13C, 13C and 13CO 
resonance assignments for mPrP(90–231) at pH = 
7.0 were generated by transfer of the published 
assignments of mPrP(121–231) at pH = 4.5, and of 
human PrP(90–230) at pH = 7.0 (29–31). The 
assignments were then confirmed using standard 
triple resonance NMR experiments with the 
uniformly 13C,15N-labeled mPrP(90–231) at pH = 
7.0. The 1HN, 15N, 13C, 13C and 13CO resonance 
assignments for all except two (see below) of the 
prion protein variants were guided by the thus 
obtained assignments for wild-type mPrP(90–
231), using HNCA, HNCO and HN(CA)CO 
spectra measured with the variant proteins. For 
mPrP[A113V,A115V,A118V](90–231), additional 
CBCA(CO)NH and HNCACB spectra were used 
to confirm the assignments. For 
mPrP[P105L,M129V](91–231) and 
mPrP[A117V,M129V](90–231) the assignments 
were derived from comparison with the chemical 
shifts of the corresponding single-residue variants. 
The 13C assignments for uniformly 13C,15N-
labeled mPrP(90–231), mPrP[P105L](91–231) and 
mPrP[A117V](90–231) in the presence of 12.9 
mM DPC were obtained using HNCA experiments 
recorded at a protein concentration of 135 M. 
All NMR experiments were performed at 
20°C on a Bruker DRX500 spectrometer equipped 
with a triply tuneable cryogenic probehead. The 
NMR data were processed with the programs 
XWINNMR and T0PSPIN 2.0, and the program 
CARA (www.nmr.ch) was used for the spectral 
analysis (31). 
Titration experiments with the detergent DPC 
– For the titration experiments, 150 M samples of 
15N-labeled protein were prepared in 5 mM 
sodium phosphate at pH = 7.0, which contained 
10% D2O. The experiments were carried out by 
the addition of aliquots of a 129 mM stock 
solution of DPC in 5 mM sodium phosphate at pH 
= 7.0, which contained 10% D2O. 2D [15N,1H]-
HSQC spectra were recorded at each DPC 
concentration in order to measure the 15N chemical 
shifts. A mean dissociation constant for the 
micelle–protein complex, KD, was obtained from 
the dependence of the 15N chemical shifts of 
selected prion protein residues on the DPC 
concentration for mPrP[P105L](90–231), using 
equation (1) (32).  
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In Eq. (1), 	(15N) is the chemical shift 
difference between the backbone amide nitrogen 
resonances at a given DPC concentration and in 
the absence of DPC, 	max is the chemical shift 
difference at the final DPC concentration,  [M0] is 
the monomeric DPC concentration, cmc is the 
critical micelle concentration, and n is the 
aggregation number of DPC. The latter two values 
were used as specified by the manufacturer 
(Anatrace, Ohio, USA), i.e., cmc = 1.5 mM and n 
= 54. 
Calculation of Hydrophobic Moments and free 
energies of transfer for residues 90130 from 
water to membrane environment – Hydrophobic 
moments were calculated according to Eisenberg 
et al. (33) using the program EMBOSS version 
5.0.0 with the function hmoment and a window 
size of 7 residues (34). Free energy changes for 
transferring amino acid residues between a lipid 
and a water environment were calculated 
according to White & Wimley using the function 
octanol from the program EMBOSS (35).
 
Results
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The prion proteins used for this study were cloned, 
expressed and purified as described in ‘Materials 
and Methods’. To establish a platform for studies 
of protein–detergent micelle interactions at a 
resolution of individual amino acid residues, we 
determined sequence-specific backbone 
assignments for all the proteins in 90% H2O/10% 
D2O containing 5 mM sodium phosphate buffer at 
pH = 7.0 and T = 20°C. The NMR assignments 
were based on standard triple resonance 
experiments (36), using a strategy described in 
‘Materials and Methods’. The backbone 
assignments are complete, with the following 
exceptions: In all the proteins the HN, 15N, 13C  
and 13CO resonances of H96 and the residues 165–
170, which are located in the 2–2 linker peptide 
segment (Fig. 1B) could not be assigned due to 
line broadening of the HN and 15N resonances 
caused by conformational exchange (37). In 
addition, the HN and 15N resonances could not be 
assigned for the residues N97, N171 and F175 in 
all the proteins, K104 in mPrP[P105L](91–231), 
V129 in mPrP[M129V](91–231), 
mPrP[P105L,M129V](91–231) and 
mPrP[A117V,M129V](90–231), and N108 in 
mPrP(90–231), mPrP[M129V](91–231) and 
mPrP[A113V,A115V,A118V](90–231). In all the 
proteins the HN, 15N, 13C and 13CO resonances of 
G93 and G94 are degenerate and could only be 
assigned as a group. In the tetrapeptide segment 
A115–A116–A117–A118, the resonances of A115 
and A118 could be assigned from the sequential 
connectivities to G114 and G119 (Fig. 1C). The 
HN and 15N resonances of A116 and A117 were 
assigned by comparing mPrP(90–231) with 
mPrP(90–231)[A117V], where the HN and 15N 
resonances of residue 117 are at chemical shifts 
typical of Val residues. The resonance assignments 
have been deposited in the BioMagResBank 
(www.bmrb.wisc.edu; accession numbers: 
mPrP(90–231), 16071; mPrP[M129V](91–231), 
16075; mPrP[P102L](91–231), 16076; 
mPrP[P105L](91–231), 16077; mPrP[A117V](90–
231), 16078; mPrP[A113V,A115V,A118V](90–
231), 16079; mPrP[K110I,H111I](90–231), 
16080). 
Screening for a membrane mimetic – At the 
beginning of our study, we tested several 
detergents and phospholipid bicelles as possible 
membrane mimetics. The best results were 
obtained with DPC, whose phosphocholine head 
groups are expected to simulate a membrane 
interface and which is the most widely used 
detergent for NMR studies of both single -helical 
membrane proteins and integral membrane -
barrel proteins (38,39). These studies include 
proteins and peptides that have been reported to be 
associated with the ER membrane such as the N-
terminal membrane anchor segment of 
thromboxane A2 synthase (40), the N-terminal 
membrane anchor domain of prostaglandin I2 
synthase (41) and cytoplasmic domain of the 
canine Sec61 gamma protein from the protein 
translocation pore of the endoplasmic reticulum 
membrane (42). 
Prion protein interactions with the detergent 
DPC – Interactions of the detergent DPC with 
mPrP(90–231) and the prion protein variants 
shown in Figure 1C were characterized by 
observing 15N chemical shift changes of the 
backbone resonances in the 2D [15N,1H]-HSQC 
spectra caused by addition of increasing amounts 
of DPC at pH = 7.0. The resonance assignments 
for the free prion proteins were used as a starting 
point, and the positions of the backbone 15N–1H 
signals were then recorded as a function of the 
concentration of added DPC. Using this approach, 
the backbone HN and 15N resonances could be 
assigned up to a DPC concentration of 40 mM in 
all the proteins except mPrP[K110I,H111I](90–
231) and mPrP[A113V,A115V,A118V](90–231). 
For the latter two proteins, assignments could only 
be obtained up to concentrations of 6.8 mM and 
18.6 mM DPC, respectively, because at higher 
DPC concentrations there was line-broadening and 
reduced solubility that prevented reliable 
assignment of the resonances. In all proteins the 
HN–15N cross peak of H111 could not be followed 
after addition of DPC, due to resonance overlap. 
Figure 2 shows superpositions of an expanded 
region of the 2D [15N,1H]-HSQC spectra obtained 
for wild-type mPrP(90–231), and for the two 
variants mPrP[P105L](91–231) and 
mPrP[A117V](90–231) in the absence and 
presence of 12.9 mM DPC. Whereas the wild type 
protein shows only small chemical shift 
differences upon addition of DPC, individual 15N 
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resonances in the two variants exhibit significant 
changes in their resonance positions and many of 
the affected resonances show significant line-
broadening of the shifted cross peaks. Because the 
HN resonances were only slightly affected, we 
performed our analysis using the 15N chemical 
shift changes. However, analysis performed with 
combined 1HN and 15N chemical shift changes do 
not change our conclusions (data not shown). 
Identification of DPC binding sites in the 
protein sequence – Histograms displaying the 
amide 15N chemical shift changes after addition of 
6.8 mM DPC for the individual residues in the 
proteins (Fig. 3) reveal that DPC interactions 
cause mainly upfield shifts of 15N resonances. In 
all the proteins, the largest 15N chemical shift 
changes between the free and DPC-bound states of 
the proteins were found for the residues 107–127, 
identifying this polypeptide segment as the DPC 
binding region. All other amino acid residues in 
the proteins were at most only slightly affected, 
except that the binding region is N-terminally 
extended to residue 102 for mPrP[P102L](91–
231), and to residue 105 for mPrP[P105L](91–
231) and mPrP[P105L,M129V](91–231) (Fig. 3C–
E). Judging from the size of the 15N chemical shift 
changes, the two designed variants 
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231) (Fig. 3H, I) show the 
strongest interaction with DPC, followed by the 
other proteins in the order mPrP[P105L](91–231) 
> mPrP[A117V](90–231) > mPrP[P102L](91–
231). Only weak interactions were observed for 
mPrP(90–231) and mPrP[M129V](91–231).
Within the aforementioned binding regions, 
the largest chemical shift changes were observed 
for the residues V113, V118 and G123 in 
mPrP[A113V,A115V,A118V](90–231), and for 
the residues V112, A113 and G123 in 
mPrP[K110I,H111I](90–231). The resonances 
which show the largest 15N chemical shift changes 
upon addition of DPC also exhibit the greatest 
degree of line-broadening.  
Comparison of pairs of proteins carrying 
either methionine or valine at position 129, with 
otherwise identical amino acid sequences, showed 
that they have nearly identical 15N chemical shift 
changes upon addition of DPC (in Fig. 3, compare 
the panels A and B, D and E, and F and G, 
respectively), indicating that the M129V 
polymorphism does not noticeably influence the 
interactions of the proteins with DPC.  
Variation of the DPC concentration shows 
that PrP interacts with detergent micelles – To 
further investigate the nature of the detergent 
interactions causing the 15N chemical shift changes 
in Figure 3, 2D [15N,1H]-correlation NMR spectra  
of mPrP[A113V,A115V,A118V](90–231) were 
measured during a titration with small DPC 
concentrations. Below the critical micelle 
concentration of 1.5 mM, no changes in the 15N 
chemical shifts were observed, indicating that the 
protein does not interact with DPC monomers, but 
is rather interacting with DPC micelles (Fig. 4). 
In order to obtain an estimate of the stability 
of the PrP–detergent micelle complexes, we 
measured 15N chemical shift changes for selected 
well-resolved resonances upon stepwise addition 
of DPC in the range above the cmc up to a 
concentration of 40 mM. Figure 5 shows for all the 
proteins studied that over this range of 
concentrations the upfield chemical shift changes 
increase monotonously with increasing DPC 
concentrations. The addition of DPC micelles also 
caused line broadening, and precipitation of 
variable fractions of the individual proteins. For  
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231), these side effects 
limited the data analysis to DPC concentrations 
below  18.6 and 6.8 mM, respectively (Fig. 5H, I). 
The slope of the 15N chemical shift changes 
versus the DPC concentration over the near-linear 
part of the curves in Figure 5 was highest for 
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231), and for the other 
proteins it decreased in the order 
mPrP[P105L](91–231), 
mPrP[P105L,M129V](91–231), 
mPrP[A117V](90–231), 
mPrP[A117V,M129V](90–231), 
mPrP[P102L](91–231), mPrP[M129V](90–231), 
mPrP(90–231) (Fig. 5). The addition of DPC 
micelles also caused line broadening, and 
precipitation of variable fractions of the individual 
proteins. For  mPrP[A113V,A115V,A118V](90–
231) and mPrP[K110I,H111I](90–231), these side 
effects limited the data analysis to DPC 
concentrations below  18.6 and 6.8 mM, 
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respectively (Fig. 5H, I). The precipitation of these 
variants is most likely caused by the higher 
affinity of these variants for the DPC micelles and 
not by structural changes or other regions that 
might get involved in membrane association, 
because all variants show similar 15N chemical 
shift changes, which indicate similar 
conformations for all variants in the DPC-bound 
state and other regions seem not to become 
additionally be affected.
Although the 15N chemical shifts show a linear 
dependence on the detergent concentration over 
most of the DPC concentration range covered in 
Figure 5, saturation at the higher DPC 
concentrations could be measured and fitted with 
Equation (1) (see Material and Methods) for 
mPrP[P105L](91–231), which shows the strongest 
binding among the proteins for which data could 
be obtained up to 40 mM DPC concentration (Fig. 
5). This approach yielded a dissociation constant, 
Kd, of 0.9  0.2 mM, which can be considered to 
represent an upper limit of the affinity of DPC 
micelles for the PrP species of Figure 1C with the 
exception of the last two species listed. These may 
bind more tightly. However, the limited solubility 
of these two species at elevated DPC 
concentrations prevents a quantitative statement 
regarding their affinity for DPC micelles.
13Cchemical shifts show that DPC induces 
helical structure in the micelle–binding region of 
PrP – The proteins mPrP[P105L](91–231) and 
mPrP[A117V](90–231) were selected for further 
studies, based on the fact that they show large 
chemical shift changes upon interaction with DPC 
and are associated with TSEs in humans, to 
quantify the population and determine the residue 
boundaries of helical conformation induced by the  
interaction with the micelles. The 13C downfield 
chemical shifts induced by the addition of DPC in 
these two proteins (Fig. 6B, C) indeed manifest 
increased -helical character of the polypeptide 
segments 102–124 and 110–122, respectively, 
which had independently been identified as the 
DPC binding regions (Fig. 3). Wild-type 
mPrP(90–231) was used as a control, and it 
showed no specific DPC effects on 13C shifts 
(Fig. 6A). 
Discussion 
The striking result of this in vitro study is that 
amino acid exchanges in PrP that are otherwise 
known to affect the susceptibility of healthy 
mammalian organisms to TSEs, have readily 
measurable effects on PrP interactions with a 
membrane mimetic. Thus, the amino acid 
substitutions P102L, P105L, and A117V, which 
are linked with familial GSS in humans, 
specifically enhance the interaction with DPC 
micelles. Gradual change of the 15N chemical 
shifts with increasing detergent concentration (Fig. 
5) indicates that there is fast exchange between 
free and micelle-associated protein, and that the 
population of bound protein is enhanced as the 
detergent concentration increases. The different 
extent of the 15N chemical shift changes for the 
different proteins provides a qualitative indication 
of the variable affinities for binding to DPC 
micelles, whereby the estimated upper limit for KD 
of 0.9 mM for the disease-related variants 
corresponds to only a modest affinity. Weak 
binding is independently supported by an analysis 
of the changes in the 13C chemical shifts observed 
upon interaction of PrP with DPC micelles (Fig. 
6). Based on the fact that a fully populated -helix 
has 	(13C)-values of 2.0 to 4.0 ppm (43,44), the 
	(13C) values of  0.4 ppm observed for 
mPrP[P105L](91–231) (Fig. 6B) suggest that 
approximately 10 to 20% of the polypeptide 
segment 102–127 adopt helical structure 
characteristic of the bound state. Similar results 
were obtained with variants of mPrP that had been 
specifically designed to increase the amount of the 
CtmPrP population in in vitro and in vivo studies 
(10,15). We consider the presently evidenced 
weak PrP–micelle interactions to be significant, 
since even a modest further increase in membrane 
affinity can lead to significant changes in the 
population of particular membrane-associated 
states of a GPI-anchored protein. 
Molecular simulations of GPI-anchored 
membrane-bound human PrP(90230) have shown 
that the N-terminal fragment 90125 is very close 
to the membrane (45). The local concentration of 
membrane binding sites for the N-terminal 
fragment of PrP can therefore be expected to be 
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greatly increased when PrP is GPI-anchored at the 
membrane, leading to significant populations of 
bound states inspite of weak affinity.   
The 15N chemical shift changes within the 
polypeptide segment of residues 102–127 show 
similar patterns for all the proteins with sizeable 
DPC affinities, indicating that they adopt similar 
conformations upon interacting with DPC micelles 
(Fig. 5). Upfield 15N chemical shift changes have 
been reported for other proteins which take on a 
helical conformation upon interaction with 
micelles (46). The observation that addition of 
DPC causes upfield shifts of nearly all backbone 
15N resonances indicates that the micelle-binding 
site of the studied PrP variants take on a more 
helical conformation in the micelle-bound state 
(Fig. 5). This conclusion is supported by the 
downfield shifts of the 13C resonances for the 
residues 110–122 of both mPrP[P105L](91–231) 
and mPrP[A117V](90–231), actually indicates that 
the binding polypeptide segment adopts -helical 
conformation in the micelle-bound state (Figs. 5 
and 6) (46,47).
For mPrP[A113V,A115V,A118V](90–231) 
and mPrP[K110I,H111I](90–231), the affinity for 
DPC micelles is the highest among all the studied 
variants consistent with the large initial slope of 
the DPC concentration-dependent curves (Fig. 5, 
panels H & I). The higher affinity of  
mPrP[A113V,A115V,A118V](90–231) and 
mPrP[K110I,H111I](90–231) for DPC micelles 
presumably results in enhanced aggregation.  
However these variants show the same pattern of 
upfield 15N shift changes indicating that they take 
on a similar conformation to the naturally 
occurring variants in the micelle-bound state. 
It is worth noting that amino acid substitutions 
at the periphery of the micelle-binding site, such 
as P102L or P105L, affect the affinity of the entire 
binding region, which has a length of 
approximately 20 residues. This suggests that the 
PrP polypeptide segment 107–127 has a 
predisposition to bind to lipid micelles, so that a 
mutation anywhere within the binding site can 
lead to an increased population of the micelle-
bound state. This conclusion is supported by the 
fact that replacement of proline, which is an “-
helix-breaker”, by leucine is expected to increase 
the -helical propensity of the local polypeptide 
segment, and it indeed results in increased DPC 
micelle affinity (Figs. 3 and 5).   
Calculation of the hydrophobic moments for 
residues 90130 of mPrP show amphipathic 
helical character for the segments 98102 and to a 
lesser extent for 109113. The substitutions P102 
and P105 tend to increase the amphipathic 
character of the two respective regions and the 
simultaneous substitutions K110I and H111I 
eliminate the second amphipathic stretch. The 
other substitutions have little effect. On the other 
hand the tendency of each residue of this segment 
to partition into a bilayer shows a good correlation 
with the order of binding affinity for DPC micelles 
which we observe experimentally. The average 
calculated 	G values for membrane insertion of 
residues 102127 are 0.0, 0.02, 0.16, 0.21, 0.23, 
0.64, 0.67, 1.97 and 2.56 kcal/mol for mPrP, 
mPrP[M129V], mPrP[P102], mPrP[P105], 
mPrP[P105,M129], mPrP[A117V], 
mPrP[A117V,M129V], 
mPrP[A113V,A115V,A118V], 
mPrP[K110I,H111I] relative to mPrP. 
No significant differences of the protein–
detergent micelle interactions are observed 
between proteins carrying either valine or 
methionine at position 129. This finding might be 
rationalized by the fact that in contrast to all other 
variable sequence locations in Figure 1C, the 
residue 129 is located within the globular C-
terminal domain (Fig. 1B). It might therefore be 
less readily accessible for contacts with detergent 
micelles. The negligible effect of the substitution 
M129V may alternatively be due to the minimal 
change in hydrophobicity caused by this 
substitution. The well-documented impact of the 
M129V polymorphism on disease-related 
processes in humans (1,2,48,49) can thus not be 
traced to an influence on the membrane affinity, 
indicating that it is due to other mechanisms. 
Previous NMR studies of interactions between 
non-globular proteins and detergent micelles have 
shown that micelles tend to interact locally with 
hydrophobic clusters, which typically consist of 
tryptophan and/or histidine residues flanked by 
hydrophobic polypeptide segments (50-54). It has 
also been shown that micelle-binding hydrophobic 
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clusters may change conformation upon binding to 
micelles (52). The micelle binding described in 
this study seems to be different from these 
previously reported hydrophobic cluster–micelle 
interactions, in that they do not require the 
presence of aromatic residues in the binding 
polypeptide segment. Actually, replacing His by 
Ile in mPrP[K110I,H111I](90–231) enhances the 
micelle–protein interaction. 
In addition to PrP, another proteins involved 
in neurodegenerative diseases, such as the A142 
peptide related to Alzheimer’s disease, which is 
derived from cleavage of the amyloid precursor 
protein (APP) by - and -secretases and has been 
shown to specifically interact with membranes 
(55,56). Recent studies have shown that PrP seems 
to play a crucial role in inhibiting the -secretase 
cleavage of APP, thereby regulating the 
production of the neurotoxic amyloid -peptide 
(57). In order to be able to downregulate the -
secretase, PrP must be integrated in lipid rafts, 
where it has been found to interact with the -
secretase via charged residues within the 
polypeptide segment 95–111 (Fig. 1B, C). 
Interestingly, PrP carrying the substitution A117V 
loses this protective function. The present study 
now shows that the substitution A117V enhances 
the affinity for ordered lipids of the polypeptide 
segment 110–122 (Fig. 3), which is located 
immediately C-terminal to the aforementioned -
secretase interaction site. The thus implicated 
increased membrane affinity could result in PrP 
being less accessible for interactions with the -
secretase.  
Conformational rearrangements induced by 
interaction with lipid phases have been discussed 
to be operative in the insertion of proteins into 
membranes (35,58). In vitro translation 
experiments with microsomes show that all variant 
prion proteins of Figure 1C exhibit an increased 
population of CtmPrP when compared to mPrP, 
with the amount of CtmPrP increasing in the order 
wild type PrP < PrP[A117V] < PrP[K110I/H111] 
< PrP[A113V/A115V/A118V] (10,12). A similar 
trend is observed when comparing the strength of 
the protein–micelle interaction affinities (Figs. 3 
and 5). Consistent with the assumption of a 
predominant role of hydrophobic contacts in the 
protein–micelle interactions, variant proteins 
carrying the designed mutations 
A113V/A115V/A118V and K110I/H111I show 
higher micelle affinity than the variants carrying 
the A117V amino acid replacement (Figs. 3 and 
5). There is thus an apparent correlation between 
the present data and the increased population of 
CtmPrP observed in the aforementioned in vitro 
translation experiments. In contrast, reports that 
methionine at position 129 significantly increases 
the population of the CtmPrP variant when 
compared to otherwise identical proteins 
containing a valine at this position (59) do not 
receive support from the present study (Figs. 3 and 
5) (see also text above). The higher affinity of the 
polypeptide segment 102127 for the ER 
membranes induced by the disease-related 
mutations might lead to an enhancement in the 
amount of the CtmPrPC form and to increased 
transport of the potential neurotoxic CtmPrP form to 
the plasma membrane, where its different 
conformation might cause cell death and disease 
progression. 
In conclusion, the present study indicates that 
the amino acid substitutions P102L, P105L and 
A117V, which have been associated with the prion 
disease GSS in humans (2,24,25), as well as the 
specifically designed substitutions K110I/H111I 
and A113V/A115V/A118V increase the affinity of 
the prion protein segment spanning the residues 
102–127 for binding to ordered lipid structures. 
The implicated enhanced affinity of the mPrP 
variants carrying the amino acid substitutions 
P102L, P105L and A117V for cellular membranes 
could either cause a loss of PrPC functions or lead 
to a gain of function, either of which might 
ultimately impact the physiological roles of PrPC 
in health as well as in the development of TSEs.  
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Figure Legends 
 
Figure 1: Detergent and proteins used in this study. (A) Zwitterionic form of dodecylphosphocholine 
(DPC). (B) Schematic diagram of the mPrP(90–231) polypeptide indicating  the locations of the regular 
secondary structures, i.e., three -helices and two strands of an antiparallel -sheet, a “positively charged 
cluster” (CC) of amino acid residues in positions 95–111, and a “hydrophobic polypeptide segment” 
(HPS) comprising residues 112–127. (C) Amino acid sequence alignment of residues 90–135 for wild-
type mPrP(90–231) and the protein variants studied in this paper, where for each variant mPrP the amino 
acid replacements are given and identical residues are indicated by dots; the numbering is according to 
Schätzl et al.(27). 
 
Figure 2: Protein 2D [15N,1H]-HSQC spectra recorded in the presence of 12.9 mM DPC (red contours) or 
without addition of DPC (blue contours). Backbone 15N–1H resonances of selected residues in the 
hydrophobic polypeptide segment (see Fig. 1) are labelled with the one-letter amino acid code and the 
positions in the sequence. The dotted lines connect corresponding peaks in the spectra recorded in the 
presence and absence of DPC. (A) mPrP(90–231). (B) mPrP[P105L](91–231). (C) mPrP[A117V](90–
231). 
 
Figure 3: Histograms of the 15N chemical shift changes induced by the addition of 6.8 mM DPC for wild-
type mPrP(90–231) and eight variants thereof. The data are plotted versus the residue numbers. At the 
top, the locations of the regular secondary structure elements in mPrP(90–231) are shown. 	(15N) is the 
difference between the 15N chemical shifts in the absence of DPC and in the presence of 6.8 mM DPC. 
The locations of the amino acid substitutions in the variant proteins are indicated by asterisks. (A) 
mPrP(90–231). (B) mPrP[M129V](91–231). (C) mPrP[P102L](91–231). (D) mPrP[P105L](91–231). (E)
mPrP[P105L,M129V](91–231). (F) mPrP[A117V](90–231). (G) mPrP[A117V,M129V](90–231). (H) 
mPrP[A113V,A115V,A118V](90–231). (I) mPrP[K110I,H110I](90–231). 
 
Figure 4: Dependence of protein 15N chemical shifts on the DPC concentration for selected residues in 
mPrP[A113V,A115V,A118V](90–231) that are identified in the upper left corner. 	(15N) is the 
difference between the 15N chemical shifts in the absence of DPC and in the presence of the DPC 
concentrations given on the horizontal axis. The dashed vertical line indicates the cmc of DPC.  
 
Figure 5: Dependence of protein 15N chemical shifts on the DPC concentration. Same presentation as in 
Figure 4, but for DPC concentrations above the cmc. The residues studied in all the experiments are 
identified in panel A. (A) mPrP(90–231). (B) mPrP[M129V](91–231). (C) mPrP[P102L](91–231). (D) 
mPrP[P105L](91–231). (E) mPrP[P105L,M129V](91–231). (F) mPrP[A117V](90–231). (G)
mPrP[A117V,M129V](90–231). (H) mPrP[A113V,A115V,A118V](90–231). (I)
mPrP[K110I,H110I](90–231). 
 
Figure 6: Histograms of 13C chemical shift changes in mPrP(90–231) and two variants thereof between 
solutions containing, respectively, 12.9 mM DPC and no DPC. The data are plotted versus the residue 
numbers. At the top, the locations of the regular secondary structures in mPrP(90–231) are indicated. 
	(13C) is the difference between the chemical shifts of the -carbons observed at 12.9 mM DPC and in 
the absence of DPC. The locations of the amino acid substitutions in the prion protein variants are 
indicated by asterisks. (A) mPrP(90–231). (B) mPrP[P105L](91–231). (C) mPrP[A117V](90–231). 
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Footnotes
Abbreviations: DPC, dodecylphosphocholine; ER, endoplasmic reticulum; GPI, 
glycosylphosphatidylinositol; HSQC, heteronuclear single quantum coherence; NTA, nitrilotriacetic acid; 
PrP, prion protein; mPrP, mouse prion protein; TSE, transmissible spongiform encephalopathy. 
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